75000 - Document - Document and Entity Information
link:presentationLink
link:calculationLink
link:definitionLink
75010 - Statement - Condensed Consolidated Balance Sheets
link:presentationLink
link:calculationLink
link:definitionLink
75020 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)
link:presentationLink
link:calculationLink
link:definitionLink
75030 - Statement - Condensed Consolidated Statements of Operations
link:presentationLink
link:calculationLink
link:definitionLink
75040 - Statement - Condensed Consolidated Statements of Comprehensive Income (Loss)
link:presentationLink
link:calculationLink
link:definitionLink
75050 - Statement - Condensed Consolidated Statements of Stockholders' Equity
link:presentationLink
link:calculationLink
link:definitionLink
75060 - Statement - Condensed Consolidated Statements of Cash Flows
link:presentationLink
link:calculationLink
link:definitionLink
995455 - Disclosure - General Organization, Business and Liquidity
link:presentationLink
link:calculationLink
link:definitionLink
995465 - Disclosure - Summary of Significant Accounting Policies
link:presentationLink
link:calculationLink
link:definitionLink
995475 - Disclosure - Cash Equivalents and Investments
link:presentationLink
link:calculationLink
link:definitionLink
995485 - Disclosure - Intangible Assets, Net
link:presentationLink
link:calculationLink
link:definitionLink
995495 - Disclosure - Inventory
link:presentationLink
link:calculationLink
link:definitionLink
995505 - Disclosure - Revenue
link:presentationLink
link:calculationLink
link:definitionLink
995515 - Disclosure - Property and Equipment, Net
link:presentationLink
link:calculationLink
link:definitionLink
995525 - Disclosure - Accrued Expenses
link:presentationLink
link:calculationLink
link:definitionLink
995535 - Disclosure - Stockholders' Equity
link:presentationLink
link:calculationLink
link:definitionLink
995545 - Disclosure - Segment Information
link:presentationLink
link:calculationLink
link:definitionLink
995555 - Disclosure - Licenses and Agreements
link:presentationLink
link:calculationLink
link:definitionLink
995565 - Disclosure - Leases
link:presentationLink
link:calculationLink
link:definitionLink
995575 - Disclosure - Legal Proceedings
link:presentationLink
link:calculationLink
link:definitionLink
995585 - Disclosure - Income Taxes
link:presentationLink
link:calculationLink
link:definitionLink
995595 - Disclosure - Summary of Significant Accounting Policies (Policies)
link:presentationLink
link:calculationLink
link:definitionLink
995605 - Disclosure - Summary of Significant Accounting Policies (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995615 - Disclosure - Cash Equivalents and Investments (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995625 - Disclosure - Intangible Assets, Net (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995635 - Disclosure - Inventory (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995645 - Disclosure - Revenue (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995655 - Disclosure - Property and Equipment, Net (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995665 - Disclosure - Accrued Expenses (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995675 - Disclosure - Stockholders' Equity (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995685 - Disclosure - Segment Information (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995695 - Disclosure - Leases (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995705 - Disclosure - General Organization, Business and Liquidity - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995715 - Disclosure - Summary of Significant Accounting Policies - Schedule of Cash and Cash Equivalents and Restricted Cash (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995725 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995735 - Disclosure - Summary of Significant Accounting Policies - Net Loss per Share (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995745 - Disclosure - Summary of Significant Accounting Policies - Income taxes & Segment Reporting (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995755 - Disclosure - Cash Equivalents and Investments - Cost and Fair Value (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995765 - Disclosure - Cash Equivalents and Investments - Available for Sale Debt Securities (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995775 - Disclosure - Cash Equivalents and Investments - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995785 - Disclosure - Cash Equivalents and Investments - Fair Value of Company's Financial Assets (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995795 - Disclosure - Intangible Assets, Net - Schedule of Gross Carrying Amounts and Net Book Value of Intangible Assets (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995805 - Disclosure - Intangible Assets, Net - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995815 - Disclosure - Inventory - Schedule of Inventories (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995825 - Disclosure - Inventory - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995835 - Disclosure - Revenue - Schedule of Net Revenue (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995845 - Disclosure - Revenue - Summary of GTN Adjustments (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995855 - Disclosure - Revenue - Schedule of Consolidated Net Product Revenue by Geographic Area (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995865 - Disclosure - Revenue - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995875 - Disclosure - Revenue - Schedule of Amount and Percentage of Gross Revenue Concentration (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995885 - Disclosure - Property and Equipment, Net - Schedule of Property and Equipment, Net (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995895 - Disclosure - Accrued Expenses - Schedule of Accrued Expenses (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995905 - Disclosure - Stockholders' Equity - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995915 - Disclosure - Stockholders' Equity - Schedule of Status of Stock Options (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995925 - Disclosure - Stockholders' Equity - Schedule of RSU Activity Including PRSUs (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995935 - Disclosure - Stockholders' Equity - Schedule of Stock-Based Compensation by Type of Award (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995945 - Disclosure - Segment Information - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995955 - Disclosure - Segment Information - Summary of Revenue, Expenses and Net Loss for the Segment and is Reconciled to Net Loss on a Consolidated Basis (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995965 - Disclosure - Segment Information - Summary of Revenue, Expenses and Net Loss for the Segment and is Reconciled to Net Loss on a Consolidated Basis (Parenthetical) (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995975 - Disclosure - Licenses and Agreements - Additonal Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995985 - Disclosure - Leases - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995995 - Disclosure - Leases - Schedule of Balance Sheet Classification of the Company's Right-of-use Asset and Lease Liabilities (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996005 - Disclosure - Leases - Schedule of Components of Lease Expenses (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996015 - Disclosure - Leases - Schedule of Maturities of the Company's Operating Lease Liabilities (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996025 - Disclosure - Leases - Schedule of Maturities of the Company's Operating Lease Liabilities (Details) 2
link:presentationLink
link:calculationLink
link:definitionLink
996035 - Disclosure - Legal Proceedings - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996045 - Disclosure - Income Taxes - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
999009 - Disclosure - Anchoring
link:presentationLink
link:calculationLink
link:definitionLink
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost
Total stock-based compensation expense
Purchase Obligation, to be Paid, Year Two
Years ending December 31, 2028
Common Stock, Capital Shares Reserved for Future Issuance
Common stock, capital shares reserved for future issuance
Schedule of Accrued Liabilities [Table Text Block]
Schedule of Accrued Expenses
Preferred Stock, Shares Issued
Preferred Stock, Shares Issued
Operating Lease, Liability
Total operating lease liabilities
Operating lease liabilities
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested
Aggregate intrinsic value of outstanding non-vested RSUs & PRSUs
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized
Total unrecognized compensation expense
Represents the member information pertaining to sublease agreement ("the New Headquarters Lease").
Sub Lease Agreement [Member]
Sub Lease Agreement
Operating Lease, Right-of-Use Asset, Amortization Expense
Amortization of right of use asset
Amount of adjustments to revenue from contract from customer for other rebates, returns, discounts and adjustments.
Adjustments For Other Rebates, Returns, Discounts And Adjustments
Other rebates, returns, discounts and adjustments
Commitments and Contingencies
Commitments and contingencies
Weighted Average Number of Shares Outstanding, Diluted
Weighted Average Shares of Common Stock Outstanding, Diluted (in shares)
Asset Acquisition [Axis]
Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition
Stock-based compensation expense
Lessee, Operating Lease, Term of Contract
Term of contract in years
Minimum
Minimum
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures
Vesting of restricted shares issued for services (in shares)
Private Placement
Private Placement
Represents information pertaining to Cellectis S.A.
Cellectis S.A
The amount of acquisitions of property and equipment included in accounts payable and accrued expense.
Acquisitions Of Property And Equipment Included In Accounts Payable And Accrued Expense
Acquisition of property and equipment included in accounts payable and accrued expenses
Preferred Stock, Shares Outstanding
Preferred stock, shares outstanding
Developed technology
Developed technology
Recurring
Recurring
Common Stock, Shares, Issued
Common Stock, Shares, Issued
Common stock, shares issued
Segment Reporting [Line Items]
Debt Instrument, Face Amount
Face amount
Income tax (expense) benefit
Income Tax Expense (Benefit)
Income tax (benefit) expense
LEGAL PROCEEDINGS
Legal Proceedings
mount of derecognition of lease liabilities at the time of termination or modification of lease agreement.
Derecognition Of Operating Lease Liabilities
Derecognition of operating lease liabilities
Amount of adjustments from gross revenues to net revenues from contract with customers.
Revenue From Contract With Customer, Gross To Net Adjustments
GTN adjustments
Total GTN adjustments
Restricted stock units
Restricted stock units
Restricted stock expense
Finite-Lived Intangible Assets, Major Class Name [Domain]
Available-for-sale Securities, Amortized Cost Basis
Amortized Cost
Operating Lease Liability [Abstract]
Operating lease liabilities
Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period
Expired/Cancelled
Inventory, Work in Process, Net of Reserves
Work in process
Operating Lease Present Value Adjustments
Less: Present value adjustment
Property, Plant and Equipment Disclosure [Text Block]
Property and Equipment, Net
Amount of increase in right-of-use asset obtained (Reduced) in exchange for operating lease liability from lease modifications.
Right of Use Asset Obtained (Reduced) In Exchange For Operating Lease Liability From Lease Modifications
Increase in lease liabilities due to obtaining right-of-use assets from lease modifications
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations
Effect of foreign exchange rate changes
Aggregate carrying value as of the balance sheet date of the inventory after valuation and LIFO reserves.
Inventory, Net, Current and Noncurrent
Total inventory
General and Administrative Expense
General and administrative
Selling, general, and administrative
Condensed Consolidated Statements of Operations
Amount of minimum restricted security deposit to be maintained.
Minimum Restricted Security Deposit
Restricted security deposit
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period
Canceled/Forfeited
Lease, Cost [Table Text Block]
Schedule of Components of Lease Expenses
Schedule of Finite-Lived Intangible Assets [Table]
Earnings Per Share, Basic
Net Loss Per Share of Common Stock, Basic (in dollars per share)
Document Period End Date
Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year
Remainder of the year ending December 31, 2026
Number of historical asset purchase agreement.
Number of Historical Asset Purchase Agreement
Number of historical asset purchase agreement
Accounts Payable and Accrued Liabilities Disclosure [Text Block]
Accrued Expenses
Series B Convertible Preferred Stock
Series B Convertible Preferred Stock
Per share or unit weighted-average fair value of fully vested and expected to vest equity-based payment instruments outstanding, excluding stock (or unit) options.
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instrument Other than Options, Vested and Expected to Vest, Outstanding, Weighted Average Grant Date Fair Value
Weighted Average Grant Date Fair Value, Ending vested and expected to vest
Finite-Lived Intangible Assets, Net
Intangible assets, net
Intangible assets, net
Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization
Cost of goods sold (excluding depreciation and amortization)
Payments to Acquire Property, Plant, and Equipment
Purchase of property and equipment
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
Issued
Common Stock, Shares Authorized
Common stock, shares authorized
Finite-Lived Intangible Asset, Expected Amortization, Year Two
Year ending December 31, 2028
Prepaid Expense and Other Assets, Current
Prepaid expenses and other assets
Foreign Currency Transactions and Translations Policy [Policy Text Block]
Foreign Currency Translation
Purchase Obligation, to be Paid, Year One
Years ending December 31, 2027
Costs and Expenses
Total costs and expenses
Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]
Disaggregation of Revenue [Table]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value
Option at ending balance
Loss Contingency, Damages Sought, Value
Damages claimed
The total number of new claims filed where the defendant has no direct liability or alleged wrongdoing.
Nominal Defendant, New Claims Filed, Number
Nominal defendant, number of new claims filed
Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent
Percentage of purchase price
Assets
Total Assets
Area of Land
Area of land
Title of 12(b) Security
Preferred Stock, Value, Issued
Preferred stock, Value
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number
Outstanding, Ending balance
Outstanding, Beginning Balance
The amortization of milestone payments.
License Agreement, Amortization of Milestone Payment
License agreement
Stock Issued During Period, Value, Stock Options Exercised
Common stock issued upon exercise of stock options
Carrying value as of the balance sheet date of obligations incurred through that date and payable for legal and related services. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Accrued Inventory, Current
Inventory and distribution related
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Issued
Customer Concentration Risk [Member]
Customer concentration
Operating Lease, Payments
Cash paid for amounts included in the measurement of lease liabilities included in cash flows from operations
Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels includes expense from PY.
Inventory Write-down Including Expense From PY
Excess and obsolescence reserve
Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]
Schedule of RSU Activity Including PRSUs
Antidilutive Securities, Name [Domain]
Stockholders' Equity Note, Stock Split, Conversion Ratio
Reverse split ratio
Effective tax rates
Effective Income Tax Rate Reconciliation, Percent
Effective tax rates
Lessee, Operating Lease, Liability, Payments, Remainder of Fiscal Year
2026
This member stands for Philadelphia, Pennsylvania.
Philadelphia, Pennsylvania
Philadelphia, Pennsylvania
Operating Leases, Future Minimum Payments, Due in Two Years
2027
Agreement Term
It represents the term of agreement.
Agreement term
Cash and Cash Equivalents [Domain]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term
Options outstanding, remaining term
The aggregate amount of write-downs for impairments recognized during the period for long lived assets due to early termination of lease.
Impairment of Long-lived Assets Due to Early Termination of Lease
Impairment due to early termination
Other comprehensive income (loss):
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]
Disaggregation of Revenue [Table Text Block]
Schedule of Disaggregation of Revenue
Maximum percentage of gross sales proceeds that will be paid as commission under the sales agreement.
Sales Agreement, Commission, Maximum Percentage Of Gross Sales Proceeds
Maximum percentage of commission
Increase (Decrease) in Operating Lease Liability
Operating lease liabilities
Lessee, Operating Leases [Text Block]
Leases
Finite-Lived Intangible Asset, Expected Amortization, Year Four
Year ending December 31, 2030
Payments to Acquire Available-for-sale Securities
Purchase of investments
The amount of milestone payment made during the period under the license agreement.
License Agreement, Milestone Payment
Amount of milestone payment made during the period under the license agreement
Stockholders' Equity Attributable to Parent
Ending Balance
Beginning Balance
Total Stockholders' Equity
Other Assets, Noncurrent
Long-term assets
Arrangements and Non-arrangement Transactions [Domain]
Income Tax Disclosure [Text Block]
Income Taxes
Carrying value as of the balance sheet date of obligations incurred through that date and payable for clinical and related services. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Clinical Related Expenses Current
Clinical related
Category of Item Purchased [Axis]
Represents the automatic renewal term of supply agreement.
Supply Agreement, Automatic Renewal Term
Renewal term of agreement
Gain (Loss) on Termination of Lease
Gain on termination of lease
Gain on derecognition of lease assets and liabilities
Amount of adjustments to revenue from contract from customer for wholesaler fees and cash discounts.
Adjustments For Wholesaler Fees And Cash Discounts
Wholesaler fees and cash discounts
Represents the required advance notice period to terminate a lease arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.
Lease Termination Notice Period
Lease termination advance notice period
Number of Reportable Segments
Number of reportable segment
Loss Contingency, New Claims Filed, Number
Number of new claims filed
STOCKHOLDERS' EQUITY
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Weighted Average Grant Date Fair Value
Office Furniture and Equipment
Office furniture and equipment
Represents information pertaining to Customer A.
Customer A [Member]
Customer A
Schedule of Stock by Class [Table]
This member stands for Patent License Agreement Related to the Development and Manufacture of TIL Therapies.
Patent License Agreement Related to the Development and Manufacture of TIL Therapies [Member]
Patent License Agreements Related to TIL Cell Therapies
Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax
Gross Unrealized Gains
Litigation Case [Axis]
Represents information manufacturing contracts.
Manufacturing Contracts [Member]
Manufacturing Contracts
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value
Weighted Average Grant Date Fair Value, Vested/Released
Intangible Assets Disclosure [Text Block]
Intangible Assets, Net
Proceeds from Stock Options Exercised
Proceeds from the issuance of common stock upon exercise of options
Short-term Lease, Cost
Short-term lease cost
Payments to Acquire Intangible Assets
Purchase of intangible assets
Purchase of intangible assets
Geographical [Domain]
Finite-Lived Intangible Asset, Expected Amortization, Year Three
Year ending December 31, 2029
Range [Axis]
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]
Stock-Based Compensation
Money market funds
Money market funds
Entity Interactive Data Current
Gain (Loss) on Extinguishment of Debt
Gain on loan forgiveness
Lessee, Operating Lease, Liability, Payments, Due Year Three
2029
Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan [Table Text Block]
Schedule of Stock-Based Compensation by Type of Award
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term
Ending vested and expected to vest, remaining term
Common stock, $0.000041666 par value; 650,000,000 shares authorized, 462,543,386 and 411,938,061 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively
Common Stock, Value, Issued
Business Description and Basis of Presentation [Text Block]
General Organization, Business and Liquidity
Royalty Expense
Royalties
Liabilities
Total Liabilities
Cost of Revenue
Cost of sales
Total cost of sales
Gain (Loss), Foreign Currency Transaction, before Tax
Unrealized foreign exchange loss (gain)
Number of historical master cell bank license and working cell bank transfer agreement.
Number of Historical Master Cell Bank License and Working Cell Bank Transfer Agreement
Number of historical master cell bank license and working cell bank transfer agreement
Utility Equipment
Represents information pertaining to utility equipment.
Utility equipment
Retained Earnings (Accumulated Deficit)
Accumulated deficit
Demand Deposits
Demand Deposits
Disclosure of information about significant accounting policies.
Accounting Policies [Table]
Increase (Decrease) in Accounts Payable
Accounts payable
Operating Expenses
Total expenses
Conversion of Stock, Shares Issued
Conversion of stock, shares issued
Liabilities, Noncurrent [Abstract]
Non-Current Liabilities
Finite-Lived Intangible Assets Acquired
Finite-lived intangible assets
Disaggregation of Revenue [Line Items]
REVENUE
Increase (Decrease) in Operating Capital [Abstract]
Changes in assets and liabilities:
Stock Issued During Period, Shares, New Issues
Common stock sold in public and/or at the market offering, net of offering costs (in shares)
Common stock sold in public offering
Information pertaining to the a new Open Market Sales Agreement (the "2023 Sales Agreement").
Sales Agreement 2023 [Member]
2023 Sales Agreement
Deferred Income Tax Liabilities, Net
Deferred tax liabilities
Represents information pertaining to other customers.
Other Customers [Member]
Other customers
IPO
IPO
Finite-Lived Intangible Assets, Accumulated Amortization
Less: accumulated amortization
Represents the cash restricted for the benefit of the landlord for its commercial manufacturing facility.
Commercial manufacturing facility
Commercial manufacturing facility
The required notification period before the party may terminate the agreement.
Notification Period To Terminate Agreement
Notification period to terminate agreement
Restricted Cash
Restricted cash
Restricted Cash, Total
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment
Less: Accumulated depreciation and amortization
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price
Expired/Cancelled
Operating Lease, Cost
Operating lease cost
Property, Plant and Equipment, Type [Axis]
Fair Value Hierarchy and NAV [Axis]
Represents the member information pertaining to Amended and Restated Open Market Sale Agreement (the "2025 Sale Agreement").
Sale Agreement 2025 Member
2025 sales Agreement
Property, Plant and Equipment [Line Items]
PROPERTY AND EQUIPMENT, NET
Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life
Weighted average amortization period
Amount of noncash expense for share-based payment arrangement included in selling, general and administrative.
Non-cash Stock-Based Compensation Included in Selling, General and Administrative
Non-cash stock-based compensation included in selling, general and administrative
Available-for-sale Securities
Total investments
Fair Value
Schedules of Concentration of Risk, by Risk Factor [Table Text Block]
Schedule of Amount and Percentage of Gross Revenue Concentration
Operating Lease, Liability, Current
Operating lease liabilities
Current portion included in current liabilities
Per share or per unit amount of equity securities issued in average price
Weighted Average Price Per Share
Weighted average price
The price per share at which the preferred stock of an entity is converted.
Convertible Price Per Shares
Convertible price per share
Option Indexed to Issuer's Equity, Type [Domain]
Concentration Risk Type [Domain]
Lessee, Operating Lease, Existence of Option to Extend [true false]
Existence of option to extend lease
Litigation Case [Domain]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value
Weighted Average Grant Date Fair Value, Ending Balance
Weighted Average Grant Date Fair Value, Beginning Balance
Customer [Domain]
Percentage of increase in monthly base rent of lease from its current amount under extension option.
Lessee, Operating Lease, Extension, Percentage of Increase in Monthly Base Rent
Percentage of increase in monthly base rent upon extension
Liabilities and Equity
Total Liabilities and Stockholders' Equity
Lessee, Operating Lease, Liability, Payments, Due Year Two
2028
Research and Development Expense
Research and development
Research and development
Finite-Lived Intangible Assets by Major Class [Axis]
Lessee, Lease, Description [Table]
Document Fiscal Period Focus
Revenue from Contract with Customer, Product and Service [Extensible Enumeration]
Inventory, Noncurrent
Inventory as long-term other assets
Inventory, Noncurrent, Total
Schedule of Inventory, Current [Table Text Block]
Schedule of Inventories
Depreciation, Depletion and Amortization, Nonproduction
Depreciation and amortization
n/a
Revenue From Contract with Customer, Gross to Net Adjustments [Abstract]
GTN adjustments:
Property, Plant and Equipment [Table]
Amount of increase (decrease) in additional paid in capital (APIC) resulting from a tax benefit (deficiency) associated with an share-based compensation plan other than an employee stock ownership plan (ESOP).
Adjustment to Additional Paid in Capital, Income Tax Effect from Share-Based Compensations, Net
Tax payments related to shares retired for vested restricted stock units
Amount of increase (decrease) in right-of-use assets from lease modifications.
Increase /(Decrease) In Right-Of-Use Assets From Lease Modifications
Increase (decrease) in right-of-use assets from lease modifications
Intellectual Property [Member]
Intellectual property license
Sale of Stock [Axis]
Purchase Obligation, to be Paid, Remainder of Fiscal Year
Remainder of the year ending December 31, 2026
Finite-Lived Intangible Asset, Useful Life
Expected useful life of intangible assets
Notes Payable, Current
Note payable - current
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect
Net increase (decrease) in cash, cash equivalents and restricted cash
Office Space
Office Space
Entity Current Reporting Status
Use of Estimates, Policy [Policy Text Block]
Use of Estimates
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number
Options exercisable
Level 1
Level 1
Class of Stock [Domain]
Costs Associated with Exit or Disposal Activities or Restructurings, Policy [Policy Text Block]
Restructuring Charges
Revenue from Contract with Customer Benchmark [Member]
Revenue
Accounts Payable, Current
Accounts payable
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]
Schedule of Antidilutive Securities Excluded from Computation of Earnings per Share
Financial Instrument [Axis]
Assets, Fair Value Disclosure
Total
Amount of noncash expense for share-based payment arrangement included in cost of sales.
Non-cash Stock-Based Compensation Included in Cost of Sales
Non-cash stock-based compensation included in cost of sales
Document Transition Report
Concentration Risk [Line Items]
REVENUE
Increase (Decrease) in Inventories
Inventory
Liabilities, Current [Abstract]
Current Liabilities
PROLEUKIN [Member]
Represents the information pertaining to Proleukin (aldesleukin), product used in the Amtagvi treatment regimen.
Proleukin
Conversion of Stock, Shares Converted
Conversion of Stock, shares converted
Amount of lessee's undiscounted obligation for lease payment for operating lease due after fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Lessee, Operating Lease, Liability, Payments, Due After Year Four
Thereafter
Common Stock
Common Stock
Inventory, Finished Goods, Net of Reserves
Finished goods
Business Combinations Policy [Policy Text Block]
Asset Acquisitions
Range [Domain]
Nonoperating Income (Expense) [Abstract]
Other income
Finite-Lived Intangible Assets, Gross
Total intangible assets
Condensed Consolidated Statements of Stockholders' Equity
Stockholders' Equity
Weighted Average Number of Shares Outstanding, Basic
Weighted Average Shares of Common Stock Outstanding, Basic (in shares)
Property, Plant, and Equipment [Abstract]
Amount of derecognition of right of use assets at the time of termination or modification of lease agreement.
Derecognition Of Operating Lease Right-Of-Use Assets
Derecognition of operating lease right-of-use assets
Inventory, Net [Abstract]
INVENTORY
Assets [Abstract]
ASSETS
Entity Central Index Key
Restructuring charges
Restructuring Charges
Restructuring Charges, Total
Antidilutive Securities [Axis]
Class of Stock [Line Items]
STOCKHOLDERS' EQUITY
Current Fiscal Year End Date
Increase (Decrease) in Accrued Liabilities
Accrued expenses and other liabilities
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Number of Shares
Document Quarterly Report
Represents the deferred consideration term for completion of the Acquisition.
Asset Acquisition, Deferred consideration term
Deferred consideration term
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets excluding non-cash amortization expense.
Amortization of Intangible Assets Excluding Non-Cash Amortization Expense
Amortization expense
This member stands for San Carlos, California.
San Carlos, California
San Carlos, California
Represents information pertaining to second manufacturing and services agreement entered with Minaris Advanced Therapies.
Second Minaris Manufacturing And Services Agreement [Member]
Second Minaris Manufacturing and services agreement
Cash and Cash Equivalents [Axis]
Number of fully vested and expected to vest equity-based payment instruments outstanding, excluding stock (or unit) options.
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instrument Other than Options, Vested and Expected to Vest, Outstanding, Number
Ending vested and expected to vest
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Outstanding, ending balance
Outstanding, beginning balance
Unrealized Gain (Loss) on Investments
Net unrealized loss on investments
Schedule of Cash and Cash Equivalents [Table]
Net Cash Provided by (Used in) Operating Activities
Net cash used in operating activities
Net cash used in operating activities
Entity Incorporation, State or Country Code
The amount of decrease in letters of credit on lease expiration.
Decrease in Letters of Credit on Lease Expiration
Decrease in letters of credit
Cooperative Research and Development Agreement
Earnings Per Share, Diluted
Net Loss Per Share of Common Stock, Diluted (in dollars per share)
Preferred Stock, Par or Stated Value Per Share
Preferred stock, par or stated value per share
Operating Lease, Weighted Average Discount Rate, Percent
Weighted-average discount rates
Net Loss
Net Loss
Net Loss
Option Indexed to Issuer's Equity, Type [Axis]
Property, Plant and Equipment, Type [Domain]
Gain (Loss) on Disposition of Assets
Loss on asset disposals
Amount of Common stock issued from preferred stock conversion.
Common Stock Issued From Preferred Stock Conversion
Common stock issued from preferred stock conversion
Lease Contractual Term [Domain]
Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Comprehensive Loss
Fair Value, Measurement Frequency [Domain]
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax
Foreign currency translation adjustment
Foreign currency cumulative translation adjustment
Equity Components [Axis]
Net Cash Provided by (Used in) Investing Activities [Abstract]
Cash Flows from Investing Activities
Condensed Consolidated Statements of Cash Flows
Fair Value Hierarchy and NAV [Domain]
INCOME TAXES
Income Taxes
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
Exercised
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
Weighted average grant date fair value, options granted
Increase (Decrease) in Prepaid Expense and Other Assets
Prepaid expenses, other assets and long-term assets
Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.
Cash, Cash Equivalents and Short-term Investments and Restricted Cash Total
Cash, cash equivalents, short-term investments, and restricted cash
Depreciation, Depletion and Amortization
Depreciation and amortization of property and equipment
Machinery and Equipment
Machinery and equipment
The total number of shares of common stock into which the convertible preferred stock may be converted, at balance sheet date.
Convertible Preferred Stock Number Of Shares Of Common Stock Available Upon Conversion, Total
Common stock available in conversion, shares
Preferred Stock, Shares Authorized
Preferred stock, shares authorized
Cash and Cash Equivalents [Line Items]
CASH EQUIVALENTS AND INVESTMENTS
Segment Reporting, Other Segment Item, Composition, Description
Other segment items
Unrealized income (loss) on investments
Other Comprehensive Income (Loss), Securities, Available-for-Sale, Unrealized Holding Gain (Loss) Arising During Period, after Tax
Long-term Purchase Commitment, Category of Item Purchased [Domain]
Class of Stock [Axis]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Antidilutive securities excluded from calculation of net loss per share
Public offering
The number of shares allegedly issued in breach of fiduciary duty, during the period.
Shares Issued in Breach of Fiduciary Duty
Number of Operating Segments
Number of operating segment
Number of operating segments
Debt Securities, Available-for-sale, Current
Short-term investments
Accumulated Other Comprehensive Income
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant
Number of shares available
Inventory, Net
Inventory
Loss Contingency, Estimate of Possible Loss
Estimate of possible loss
Segment Reporting, Policy [Policy Text Block]
Segment Reporting
Non-US
Rest of world
Concentration Risk Benchmark [Domain]
The cash inflow from the additional capital contribution to the entity under Employee Stock Purchase Plan.
Proceeds from Issuance of Common Stock, Under Employee Stock Purchase Plan
Proceeds from the issuance of common stock under employee stock purchase plan
Accrued Liabilities, Current
Total accrued expenses
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
STOCKHOLDERS' EQUITY
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number
Outstanding, ending balance
Outstanding, beginning balance
Customer [Axis]
Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax
Gross Unrealized Losses
INTANGIBLE ASSETS, NET
Research and Development Expense, Policy [Policy Text Block]
Accrued Research and Development Costs
Document Type
Cash and Cash Equivalents, Policy [Policy Text Block]
Cash, Cash Equivalents, and Investments
The entire disclosure for licenses and agreements.
Licenses And Agreements Disclosure [Text Block]
Licenses and Agreements
Net Cash Provided by (Used in) Operating Activities [Abstract]
Cash Flows from Operating Activities
Liabilities and Equity [Abstract]
LIABILITIES AND STOCKHOLDERS' EQUITY
Lessee, Lease, Description [Line Items]
LEASES
Stock option expense
Operating Income (Loss)
Loss from operations
Disclosure of inventory and cost of sales accounting policy.
Inventories and Cost of Sales [Policy Text Block]
Inventory and Cost of Sales
Segment Reporting [Table]
Selling and Marketing Expense
Sales and marketing
Entity File Number
Revenue from Contract with Customer [Text Block]
Revenue
The amount of equity claim.
Equity Claim
Equity claim
Accrued Liabilities and Other Liabilities
Accrued expenses and other liabilities
Lab, Process, and Validation Equipment
Lab, process, and validation equipment
Lessee, Operating Lease, Liability, Maturity [Table Text Block]
Schedule of Maturities of the Company's Operating Lease Liabilities
Accumulated Deficit
Number of options to extend the lease.
Lessee, Operating Lease, Number of Options to Extend Lease
Number of options to extend the lease
Represents the information pertaining to Novartis pharma AG and Related Entities License Agreement.
Novartis Pharma AG And Related Entities License Agreement [Member]
Novartis Pharma AG and Related Entities - License Agreement
Entity Registrant Name
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Summary of Significant Accounting Policies
Facility leases
Lessee, Operating Lease, Renewal Term
Renewal term in years
Cash, Cash Equivalents, and Short-term Investments [Text Block]
Cash Equivalents and Investments
Entity Address, Address Line One
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]
Weighted Average Exercise Price
UNITED STATES
United States
Inventory, Raw Materials, Net of Reserves
Raw materials
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
Common stock issued upon exercise of stock options (in shares)
Exercised
Contingencies Disclosure [Text Block]
Legal Proceedings
This member stands for Second Amended and Restated Patent License Agreement.
Second Amended and Restated Patent License Agreement [Member]
Second Amended and Restated Patent License Agreement
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price
Options exercisable
Assets, Current
Total Current Assets
Furniture and equipment
Earnings Per Share, Policy [Policy Text Block]
Net Loss per Share
Segments [Axis]
Loss Contingencies [Line Items]
LEGAL PROCEEDINGS
The payment term of customers.
Customer Payment Term
Customer payment term
Carrying value as of the balance sheet date of obligations incurred through that date and payable for manufacturing of the entity's goods and services. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Manufacturing Related Expenses Current
Manufacturing related
Deferred Income Tax Expense (Benefit)
Deferred tax benefit
Entity Small Business
Ending vested and expected to vest
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES.
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
Summary of Significant Accounting Policies
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options
Unrecognized compensation cost
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value
Weighted Average Grant Date Fair Value, Canceled/forfeited
The number of suites under the agreement.
Number Of Suites Under The Agreement
Number of suites under the agreement
Proceeds from Sale and Maturity of Debt Securities, Available-for-sale
Maturities of investments
Significant Accounting Policies [Text Block]
Summary of Significant Accounting Policies
Accounts Receivable, after Allowance for Credit Loss, Current
Trade accounts receivable
Represents information pertaining to manufacturing and supply agreement from Clinigen with Boehringer Ingelheim Biopharmaceuticals GmbH.
Manufacturing and Supply Agreement With Boehringer Ingelheim Biopharmaceuticals GmbH [Member]
Manufacturing and Supply Agreement With Boehringer Ingelheim Biopharmaceuticals GmbH
Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]
Intangible Assets
Maximum amount of shares that can be issued under sale agreement.
Sales Agreement, Authorized Shares To Be Issued, Amount
Maximum amount of shares to be issued
Share-based Compensation, Stock Options, Activity [Table Text Block]
Schedule of Status of Stock Options
Lessee, Operating Lease, Liability, Payments, Due Year Four
2030
Plan Name [Axis]
Information pertaining to lawsuit brought by Solomon Capital LLC et al.
Solomon Capital LLC Litigation
Represents the assembled workforce acquired in an asset acquisition.
Assembled Workforce [Member]
Assembled workforce
Stockholders' Equity Note Disclosure [Text Block]
Stockholders' Equity
Measurement Frequency [Axis]
Net Cash Provided by (Used in) Financing Activities [Abstract]
Cash Flows from Financing Activities
Period within which the company is required to be remit the specified amount under the collaborative arrangement.
Collaborative Arrangement, Period To Remit Required Amount
Period of collaborative arrangement required to be remitted
Liabilities, Noncurrent
Total Non-Current Liabilities
Entity Tax Identification Number
Stock Issued During Period, Shares, Conversion of Convertible Securities
Conversion of convertible preferred stock into common stock (in Shares)
Accounts Receivable [Policy Text Block]
Trade Accounts Receivable
Equity Component [Domain]
The cash outflow for payment of contingent consideration associated with the asset acquisition.
Payments of Contingent Consideration for Asset Acquisition
Contingent consideration paid for acquisition
Entity Address, City or Town
Finite-Lived Intangible Assets, Net [Abstract]
Gross carrying amounts and net book value of intangible assets
Finite-Lived Intangible Assets [Line Items]
INTANGIBLE ASSETS, NET
Stock Issued During Period, Value, New Issues
Common stock sold in public and/or at the market offering, net of offering costs
Restricted Cash, Noncurrent
Restricted cash
Segments [Domain]
The amount of milestone payments payable under the license agreement.
License Agreement Milestone Payments Payable
Amount of milestone payments payable under the license agreement
Entity Common Stock, Shares Outstanding
Concentration Risk Type [Axis]
Inventory Write-down
Excess and obsolescence reserve
Represents information pertaining to at the market offering program.
At the Market Offering Program
At the Market Offering Program
Represents information pertaining to employee stock purchase plan.
Employee Stock Purchase Plan
Employee Stock Purchase Plan
Represents information pertaining to Two Thousand Twenty One Inducement Plan.
2021 Inducement Plan
2021 Inducement Plan
Amount of noncash expense for share-based payment arrangement included in Research and development.
Non-cash Stock-Based Compensation Included in Research and Development
Non-cash stock-based compensation included in research and development
Lessee, Operating Lease, Option to Extend
Option to extend
Remaining amount of shares that can be issued under sale agreement.
Sales Agreement, Authorized Shares Remaining To Be Issued, Amount
Remaining amount of shares
Statement [Table]
Lease, Cost
Total lease cost
Allocated Share-based Compensation Expense
Stock-based compensation expense
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest
Net Loss before income taxes
Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]
Summary of Revenue, Expenses and Net Loss for the Segment and is Reconciled to Net Loss on a Consolidated Basis
Entity Shell Company
Net Cash Provided by (Used in) Investing Activities
Net cash provided by (used in) investing activities
Tabular disclosure of supplemental balance sheet information related to leases
Supplemental Balance Sheet Information Related To Leases [Table Text Block]
Schedule of Balance Sheet Classification of the Company's Right-of-use Asset and Lease Liabilities
Statement [Line Items]
Company's equity incentive plans
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period
Vested/Released
Maximum
Maximum
Amount of expenses related to initiation of patient dosing, recorded during the period.
Patient Dosing Initiation Expenses
Patient dosing initiation expenses
Sale of Stock [Domain]
Twenty Eighteen Equity Incentive Plan Member.
The 2018 Plan
The 2018 Plan
Investment Income, Interest
Interest and other income, net
Represents information pertaining to Restricted Stock Units (RSUs) including Performance-Based Restricted Stock Units (PRSUs).
RSUs and PRSUs
RSUs and PRSUs
Disclosure of information about licenses and agreements.
Licenses and Agreements [Table]
Construction in Progress
Construction in progress
Concentration Risk Benchmark [Axis]
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent
Federal statutory tax rate
Tabular disclosure of the components of cash, cash equivalents and Restricted Cash.
Schedule of Cash and Cash Equivalents and Restricted Cash [Table Text Block]
Schedule of Cash and Cash Equivalents and Restricted Cash
Consolidation, Policy [Policy Text Block]
Principles of Consolidation
Payments Related to Tax Withholding for Share-based Compensation
Tax payments related to shares withheld for vested restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value
Weighted Average Grant Date Fair Value, Granted
Concentration Risk [Table]
Assets, Current [Abstract]
Current Assets
Accrued Professional Fees, Current
Legal and related services
Amount, before adjustments, of revenue from satisfaction of performance obligation by transferring promised good or service to customer.
Revenue From Contract With Customer, Gross
Gross revenue
Gross revenue
Amount of impairment of investment in debt security, measured at amortized cost (held-to-maturity), charged against allowance for credit loss.
Debt Securities, Available-for-Sale, Allowance for Credit Loss, Impairment Loss
Impairment losses related to credit losses
Leases
Document Fiscal Year Focus
Share-Based Payment Arrangement, Noncash Expense [Abstract]
Non-cash stock-based compensation included in cost of sales and operating expenses
Accretion (Amortization) of Discounts and Premiums, Investments
Accretion of discounts and premiums on investments
Common Stock, Shares, Outstanding
Common Stock, Shares, Outstanding
Common stock, shares outstanding
Security Deposit
Security deposit
Financial Instruments [Domain]
Condensed Consolidated Statements of Comprehensive Loss
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value
Option exercisable
Revenue from Contract with Customer [Policy Text Block]
Revenue Recognition
n/a
Aggregate Intrinsic Value
Operating Lease, Liability, Noncurrent
Operating lease liabilities - non-current
Long-term portion included in non-current liabilities
Schedule of Finite-Lived Intangible Assets [Table Text Block]
Schedule of Gross Carrying Amounts and Net Book Value of Intangible Assets
Lessee, Operating Lease, Liability, Payments, Due
Total lease payments
Other Accrued Liabilities, Current
Other accrued expenses
Security Exchange Name
Amount required to be remitted under the collaborative arrangement .
Collaborative Arrangement, Amount Required To Be Remitted
Amount of collaborative arrangement required to be remitted
New Accounting Pronouncements, Policy [Policy Text Block]
Recently Issued and Adopted Accounting Pronouncements
Entity Address, State or Province
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition
Unrecognized compensation cost recognition period
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Number of Options
Series A Convertible Preferred Stock
Series A Convertible Preferred Stock
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized
Shares authorized
Operating Lease, Right-of-Use Asset
Operating lease right-of-use assets
CASH EQUIVALENTS AND INVESTMENTS
N/A.
Amendment Flag
Loss Contingencies [Table]
Concentration Risk, Percentage
Concentration risk (in percent)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
Cash, Cash Equivalents and Restricted Cash End of Period
Cash, Cash Equivalents and Restricted Cash Beginning of Period
Total cash, cash equivalents and restricted cash
City Area Code
Stock Issued During Period, Value, Employee Stock Purchase Plan
Common stock issued upon purchase of employee stock purchase plan
Preferred Stock
Preferred Stock
Fair Value, Assets Measured on Recurring Basis [Table Text Block]
Schedule of Fair Value of the Company's Financial Assets
Two Thousand Twenty Espp Member.
2020 ESPP
2020 ESPP
ESPP expense
The amount of cash outflow associated with the payment of early termination.
Lessee, Operating Lease, Amount of Early Lease Termination Fees Paid
Early termination payment
GENERAL ORGANIZATION, BUSINESS AND LIQUIDITY
Proceeds from Issuance of Common Stock
Proceeds from the issuance of common stock, net
Proceeds from Other Debt
Proceeds from lawsuit filed
Unrealized Gain (Loss) on Investments [Table Text Block]
Schedule of Cost and Fair Value of Cash Equivalents and Short-term Investments
Operating Expenses [Abstract]
Expenses
Costs and expenses
Computer Equipment
Computer equipment
Inventory Disclosure [Text Block]
Inventory
Represents the information pertaining to Blank Check.
Blank check
Blank check
Conversion of Stock, Amount Converted
Conversion of convertible preferred stock to common stock
Restricted Cash and Cash Equivalents [Axis]
Accrued Employee Benefits, Current
Accrued payroll and employee related expenses
Common Stock, Par or Stated Value Per Share
Common stock, par or stated value per share
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term
Options exercisable, remaining term
Lessee, Leases [Policy Text Block]
Leases
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number
Ending vested and expected to vest
Liabilities, Current
Total Current Liabilities
Leasehold Improvements
Leasehold improvements
Carrying value as of the balance sheet date of obligations incurred through that date and payable for commercial manufacturing facility related services. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Commercial Manufacturing Facility Related Current
Facilities related
Property, Plant and Equipment, Gross
Total property and equipment, cost
Variable Lease, Cost
Variable lease cost
Segment Reporting Disclosure [Text Block]
Segment Information
Debt Securities, Available-for-sale [Table Text Block]
Schedule of Available-for-sale Debt Securities
Type of Arrangement and Non-arrangement Transactions [Axis]
Area of land surrendered.
Area of Land Surrendered
Area of land surrendered
Trading Symbol
The percent of milestone payments reimbursable by deduction from deferred consideration.
License Agreement, Percent of Milestone Payments Reimbursable
Percent of milestone payments reimbursable
Geographical [Axis]
Property, Plant and Equipment [Table Text Block]
Schedule of Property and Equipment, Net
Share-Based Payment Arrangement, Amount Capitalized
Stock-based compensation expense
Number of historical license agreement.
Number of Historical License Agreement
Number of historical license agreement
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period
Granted
Entity Emerging Growth Company
Additional Paid-In Capital
For an entity that discloses threshold for concentration of credit risk of customers.
Threshold For Concentration Of Credit Risk
Threshold for concentration of credit risk
Represents the information pertaining to patent license agreement related to the company sponsored Phase 2 Clinical Study in Melanoma.
Patent License Agreement, Related to Phase 2 Clinical Study in Melanoma [Member]
Phase 2 Clinical Study in Melanoma
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Number of Positions
Number of investments in debt securities in continuous unrealized loss position for more than 12 months
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
Licenses and Agreements [Line Items]
Licenses and Agreements
Plan Name [Domain]
Selling, General and Administrative Expenses, Policy [Policy Text Block]
Selling, General, and Administrative Expense
Number of Common stock issued from preferred stock conversion.
Common Stock Issued From Preferred Stock Conversion, Shares
Common stock issued from preferred stock conversion (in Shares)
Stock Issued During Period, Shares, Employee Stock Purchase Plans
Common stock issued upon purchase of employee stock purchase plan (in shares)
U.S. treasury securities
U.S. treasury securities
Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]
Supplemental disclosure of non-cash investing and financing activities:
Document And Entity Information
Segment Reporting, Other Segment Item, Amount
Other segment items
Debt Instrument, Convertible, Number of Equity Instruments
Debt instrument, convertible, number of equity instruments
Represents information pertaining to single reportable segment.
Single Reportable Segment [Member]
Single Reportable Segment
Operating Lease, Weighted Average Remaining Lease Term
Weighted-average remaining lease terms (years)
Revenue from Contract with Customer [Abstract]
Tabular disclosure for gross to net adjustments recorded in revenue.
Schedule Of Gross to Net Adjustments in Revenue [Table Text Block]
Schedule of GTN Adjustments Recorded in Revenue
Accumulated Other Comprehensive Income (Loss), Net of Tax
Accumulated other comprehensive income
Amortization of Intangible Assets
Amortization of intangible assets
Share-based Compensation
Stock-based compensation expense
Share-based Compensation
Additional Paid in Capital
Additional paid-in capital
LICENSES AND AGREEMENTS
Licenses and Agreements
Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]
Adjustments to reconcile net loss to net cash used in operating activities:
Short-term investments
Short-term investments
Cash and Cash Equivalents, at Carrying Value
Cash and cash equivalents
Cash and cash equivalents
Cash and Cash Equivalent, Total
Debt Securities, Available-for-sale, Unrealized Loss
Unrealized losses on available-for-sale
Net Cash Provided by (Used in) Financing Activities
Net cash provided by financing activities
Computer Software
Represents information pertaining to computer software.
Computer Software [Member]
ACCRUED EXPENSES
The amount of monthly base rent under operating lease of lessee.
Lessee, Operating Lease, Monthly Base Rent
Monthly base rent
Cash Equivalents, at Carrying Value
Cash equivalents total
Cash equivalents
Entity Filer Category
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price
Ending vested and expected to vest
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRemainingContractualLife [Abstract]
Weighted Average Remaining Contractual Life (Years)
The amount of share-based compensation included in cost of sales.
Stock-based Compensation Included in Cost of Sales
Stock-based compensation
Lease Contractual Term [Axis]
Disclosure of accounting policy for restricted cash.
Restricted Cash [Policy Text Block]
Restricted Cash
Increase (Decrease) in Accounts Receivable
Trade accounts receivable
Finite-Lived Intangible Asset, Expected Amortization, Year One
Year ending December 31, 2027
Amount of adjustments to revenue from contract from customer for Government rebates and chargebacks.
Adjustments For Government Rebates And Chargebacks
Government rebates and chargebacks
Property, Plant and Equipment, Net
Property and equipment, net
Property and equipment, net
Patents [Member]
Patents
Shares increase (decrease) in additional paid in capital (APIC) resulting from a tax benefit (deficiency) associated with an share-based compensation plan other than an employee stock ownership plan (ESOP).
Adjustments To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net Shares
Tax payments related to shares retired for vested restricted stock units (in shares)
Revenue from Contract with Customer, Excluding Assessed Tax
Total revenue
Net revenue
Net sales
Shares, Outstanding
Ending Balance (in Shares)
Beginning Balance (in Shares)
INVENTORY
Asset Acquisition [Domain]
The amount of cash outflow associated with the payment of related brokerage fees.
Lessee, Operating Lease, Amount of Brokerage Fee Paid
Brokerage fees paid
SEGMENT INFORMATION
Entity Address, Postal Zip Code
Represents the information pertaining to Amtagvi (lifileucel), the first product within its autologous TIL cell therapy platform.
Amtagvi [Member]
Amtagvi
Condensed Consolidated Balance Sheets
Local Phone Number
Represents information relating to New Headquarters Lease.
New Headquarters Lease